Shire rejects £42.4bn Takeda bid
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Syndicated LoansInvestment Grade Loans

Shire rejects £42.4bn Takeda bid

Pharmaceutical 230x150

Irish pharmaceutical company Shire has turned down a £42.4bn takeover offer from Takeda, putting pressure on the Japanese company’s ambitions for global expansion as it strives to maintain its dividend and investment grade rating.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article